ClinConnect ClinConnect Logo
Search / Trial NCT04851678

Longitudinal Impact of Stressors in Adults With Tourette Syndrome

Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Apr 14, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Stress Environmental Stress Psychosocial Stress

ClinConnect Summary

This clinical trial, titled "Longitudinal Impact of Stressors in Adults With Tourette Syndrome," is looking to understand how stress throughout life affects adults with Tourette Syndrome (TS). Over two years, researchers will study how different stressors influence the severity of tics (the involuntary movements or sounds associated with TS), mental health issues that often occur alongside TS, and overall quality of life for those affected.

To participate, individuals must be over 18 years old and have a diagnosis of Tourette Syndrome or related tic disorders. They should be able to give informed consent and speak English. However, those with serious medical or mental health conditions, like uncontrolled epilepsy or schizophrenia, cannot take part in the study. Participants can expect to be part of assessments that track their experiences and challenges over time, which could help improve understanding and treatment for Tourette Syndrome in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adults (\>18) meeting Diagnostic and Statistics Manual, 5th edition (DSM-V) criteria for Tourette syndrome, chronic motor tic disorder, or chronic vocal tic disorder
  • ability to provide informed consent
  • English proficiency
  • Exclusion Criteria:
  • - significant medical, neurologic, or psychiatric diagnoses (e.g. uncontrolled epilepsy, chronic heart failure, schizophrenia) besides TS and its commonly co-occurring psychiatric diagnoses

About Vanderbilt University Medical Center

Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.

Locations

Nashville, Tennessee, United States

Nashville, Tennessee, United States

Patients applied

0 patients applied

Trial Officials

David A Isaacs, MD, MPH

Principal Investigator

Vanderbilt University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials